Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by captwadeon Oct 13, 2020 5:52pm
173 Views
Post# 31711385

RE:RE:RE:Mr. Market is wrong on this?

RE:RE:RE:Mr. Market is wrong on this?Totally agree with you guys. In this case the market is wrong. There is however, I think, a logical reason that those of us on Stockhouse would feel that way. As I have mentioned here before, thanks to the great sleuthing by some of you, we are among the most knowledgable of CZO shareholders. and, probably logical that we are therefore among the most frustrated. Our day will come, and soon.

I think we will have earnings in Q3 and Q4.  Someone on here said awhile back that it may be wrong to extrapolate earnings for Q3 and Q4 and any other year I would agree, but this year may be different because CZO is a net beneficiary of this Covid mess. We also could have an earnings surprise because I seem to recall that Gagnon's idea of a proper UCC deal would include upfront money, and of course, there would be no cost of goods associated with that money. Pure profit.

I listened to the recent presentation again last nite and I must admit something had previously gone over my head. When Gagnon made reference to the,'masterpiece"of CZO strategy I had assumed he meant the PGX technology. Listening again {and again} last nite it was clear that he was referring to the PGX-YBG as the masterpiece of CZO strategy. So, something we didn't even have six months ago and, I would assume, have yet to sell to anyone is suddenly the jewel-in-the-crown. There may be only one explanation for Gagnon's declaration of 'masterpiece'  I'm guessing that the preliminary preclinical data on the inhalation study may have been so positive, so exciting, that management have decided in their mind that CZO does indeed have an effective Covid19 therapeutic. That would be huge as cases continue to spike worldwide.

I'm with CIAO, this is at least a 10 banger.    
<< Previous
Bullboard Posts
Next >>